Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000054

PRESIDENT AND CFO sold 8,000 shares at an average $78.58 ($628,650)

  • PRESIDENT AND CFO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-08-19 Option exercise 10b5-1 +8,000 $5.35 $42,800 104,720 D: show line 1 in the form
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-08-19 Sale 10b5-1 −4,994 $78.25 $390,771 99,726 D: show line 2 in the form
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-08-19 Sale 10b5-1 −3,006 $79.14 $237,880 96,720 D: show line 3 in the form
Open-market sales · 8,000 sh · avg $78.58 · $628,650

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-08-19 Option exercise · Stock Option (right to buy) 10b5-1 −8,000 328,827 D: show line 4 in the form
Loading xslF345X05/wk-form4_1724186989.xml…